Portfolio Lab

Thermo Fisher Scientific Inc.

  • Stock
  • Ticker TMO
  • ISIN US8835561023
  • NYSE

Technology · Electronics and instruments · USA

$669.54 −2.79%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Thermo Fisher Scientific Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

TMOGlobal equities (VT)

$10,000 grew to $47,118. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −41.0% in 06/2025, measured from the peak in 12/2021. It took 57 months to get back to the old peak.

1-year return
+17.3%
5-year return p.a.
+1.3%
10-year return p.a.
+16.8%
Volatility p.a.
23.6%
Largest decline
−41.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue11,39510,36410,85511,12212,21511,00511,99412,137
Operating income2,0161,7161,8341,9412,2551,8632,0872,263
EBITDA2,3201,9922,0902,1682,5472,1692,4182,570
Net income1,8301,5071,6171,6161,9641,6511,7361,721
Earnings per share4.783.984.284.275.214.434.684.64
Balance sheet
Total assets97,32199,041101,230103,020110,343113,281113,174114,233
Liabilities47,77049,68450,75451,99656,92861,34160,48859,466
Equity49,58449,39050,51251,01853,40751,93452,67954,761
Cash4,0094,1344,5761,9829,8523,2544,0645,461
Long-term debt31,07233,98935,03335,48439,17242,94742,28441,108
Cash flow
Operating cash flow3,2907231,3992,2393,4571,1922,1252,550
Capital expenditure-480-362-294-404-465-376-450-437
Free cash flow2,8103611,1051,8352,9928161,6752,113

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +45.5%, weakest 2022 at −17.3%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
30 Oct 2026$4.64
31 Jul 2026$4.68
1 May 2026$4.43
26 Feb 2026$5.21
31 Oct 2025$4.27
1 Aug 2025$4.28
2 May 2025$3.98
20 Feb 2025$4.78
1 Nov 2024$4.25
2 Aug 2024$4.04
3 May 2024$3.46
22 Feb 2024$4.20

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€225bn
Market cap in trading currency
$248bn
Enterprise value
$283bn
P/E
35.3
P/S
5.24
P/B
4.53
EV/Sales
5.98
EV/EBITDA
29.2
Earnings yield
2.8%
FCF yield
3.1%

Results (last four quarters)

Revenue
$47.4bn
Gross profit
–
EBITDA
$9.70bn
Net income
$7.07bn
Earnings per share
$18.96
Revenue per share
$127.80
Revenue growth
+9.1%
Earnings growth
+6.5%

Profitability

Gross margin
–
Operating margin
17.9%
Net margin
14.9%
Return on equity
13.4%
Return on assets
6.2%

Balance sheet and cash flow

Cash
$6.06bn
Cash per share
$16.36
Financial debt
$41.1bn
Debt/equity %
75
Current ratio
1.81
Book value per share
$147.80
Operating cash flow
$9.32bn
Free cash flow
$7.60bn

Dividend

Dividend yield
0.27%
Dividend (12 months)
$1.84
Yield (12 months)
0.27%
Payout ratio
10%
Ex-dividend date
15 Sep 2026

Shares and trading

Shares outstanding
371m
Volume
2.35m
Avg. volume 3 months
2.17m
Relative volume
1.1

Price and technicals

Price
$669.54
1 day
−2.8%
52-week high
$721.63
52-week low
$438.34
Distance to 52-week high
−7.2%
Distance to 52-week low
+52.7%
Distance to 50-day line
−1.3%
Distance to 200-day line
+19.9%
RSI (14)
43
Volatility 1M
31.3%

Performance

1 week
−4.4%
1 month
−1.0%
3 months
+6.5%
6 months
+49.4%
YTD
+15.5%
1 year
+16.7%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
26 Sep 2026

Frequently asked questions

How has TMO performed since 11/2016?

$10,000 grew to $47,118 by 20 Nov 2026, which is +16.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is TMO?

Volatility was 23.6% per year, measured on monthly returns. The largest decline from a peak was −41.0%, with the low in 06/2025.

How does TMO compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, TMO returned +16.8% at 23.6%. The correlation of monthly returns was 0.50; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Thermo Fisher Scientific Inc. (TMO): Return and risk